Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Learn Zero Based Budgeting strategies tailored for single income households, focusing on prioritization, debt control, and savings.
25,731 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
A $1,000 invest? here’s what XRP and Bitcoin could be worth by 2027, depending on regulatory outcomes for XRP and mac...
Ethereum hit a six-week high above $1,900, extending gains after cooler inflation data. Analysts point to a mix of ma...
The Metals Company stock faced a sharp pullback in early 2026 after a dramatic rally in the previous year. This artic...
Google’s Gemini AI released a bold Solana forecast, pairing a performance upgrade roadmap with a price trajectory tha...
Hyperliquid's AQAv2 upgrade pushes HYPE higher as Coinbase and Circle commit to the new stablecoin framework, alignin...
SpaceX is charging toward a historic IPO, aiming for a mid-June pricing and a Nasdaq debut under SPCX. The deal could...
Investors are weighing Alibaba's AI and cloud ambitions against profits and regulatory headwinds. This guide breaks d...
Bank of America's latest fund-manager survey shows investors all-in stocks with dwindling cash buffers. As June appro...
Escrow audits are back in focus as regulators tighten oversight. Title agencies are adopting a formal escrow audit re...
Micron reports robust Q3 guidance and signs a five-year strategic deal, fueling optimism that the AI memory cycle cou...
Whale buyers snapped up hundreds of millions of DOGE as SpaceX filed for a Nasdaq debut. The surge boosts bets that d...